Cerus Price to Sales Ratio 2010-2025 | CERS
Historical PS ratio values for Cerus (CERS) over the last 10 years. The current P/S ratio for Cerus as of June 26, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Cerus P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-06-26 | 1.36 | 1.22 | |
| 2025-03-31 | 1.39 | $1.11 | 1.25 |
| 2024-12-31 | 1.54 | $1.09 | 1.41 |
| 2024-09-30 | 1.74 | $1.08 | 1.61 |
| 2024-06-30 | 1.76 | $1.07 | 1.65 |
| 2024-03-31 | 1.89 | $1.06 | 1.78 |
| 2023-12-31 | 2.16 | $1.04 | 2.08 |
| 2023-09-30 | 1.62 | $1.03 | 1.57 |
| 2023-06-30 | 2.46 | $1.03 | 2.38 |
| 2023-03-31 | 2.97 | $1.04 | 2.86 |
| 2022-12-31 | 3.65 | $1.07 | 3.42 |
| 2022-09-30 | 3.60 | $1.07 | 3.37 |
| 2022-06-30 | 5.29 | $1.05 | 5.02 |
| 2022-03-31 | 5.49 | $1.00 | 5.47 |
| 2021-12-31 | 6.81 | $0.93 | 7.30 |
| 2021-09-30 | 6.09 | $0.85 | 7.20 |
| 2021-06-30 | 5.91 | $0.78 | 7.62 |
| 2021-03-31 | 6.01 | $0.72 | 8.37 |
| 2020-12-31 | 6.92 | $0.70 | 9.89 |
| 2020-09-30 | 6.26 | $0.68 | 9.15 |
| 2020-06-30 | 6.60 | $0.67 | 9.83 |
| 2020-03-31 | 4.65 | $0.67 | 6.93 |
| 2019-12-31 | 4.22 | $0.67 | 6.26 |
| 2019-09-30 | 5.16 | $0.64 | 8.07 |
| 2019-06-30 | 5.62 | $0.62 | 9.06 |
| 2019-03-31 | 6.23 | $0.61 | 10.28 |
| 2018-12-31 | 5.07 | $0.58 | 8.71 |
| 2018-09-30 | 7.21 | $0.60 | 12.01 |
| 2018-06-30 | 6.67 | $0.58 | 11.59 |
| 2018-03-31 | 5.48 | $0.53 | 10.26 |
| 2017-12-31 | 3.38 | $0.48 | 7.05 |
| 2017-09-30 | 2.73 | $0.42 | 6.43 |
| 2017-06-30 | 2.51 | $0.41 | 6.17 |
| 2017-03-31 | 4.45 | $0.39 | 11.37 |
| 2016-12-31 | 4.35 | $0.39 | 11.25 |
| 2016-09-30 | 6.21 | $0.37 | 16.83 |
| 2016-06-30 | 6.24 | $0.35 | 17.83 |
| 2016-03-31 | 5.93 | $0.35 | 16.89 |
| 2015-12-31 | 6.32 | $0.36 | 17.77 |
| 2015-09-30 | 4.54 | $0.38 | 11.91 |
| 2015-06-30 | 5.19 | $0.43 | 11.93 |
| 2015-03-31 | 4.17 | $0.46 | 9.10 |
| 2014-12-31 | 6.24 | $0.48 | 12.96 |
| 2014-09-30 | 4.01 | $0.49 | 8.14 |
| 2014-06-30 | 4.15 | $0.51 | 8.17 |
| 2014-03-31 | 4.80 | $0.53 | 9.00 |
| 2013-12-31 | 6.45 | $0.59 | 10.90 |
| 2013-09-30 | 6.72 | $0.65 | 10.40 |
| 2013-06-30 | 4.42 | $0.64 | 6.86 |
| 2013-03-31 | 4.42 | $0.67 | 6.60 |
| 2012-12-31 | 3.16 | $0.67 | 4.70 |
| 2012-09-30 | 3.40 | $0.70 | 4.87 |
| 2012-06-30 | 3.32 | $0.74 | 4.49 |
| 2012-03-31 | 4.02 | $0.71 | 5.63 |
| 2011-12-31 | 2.80 | $0.69 | 4.07 |
| 2011-09-30 | 2.12 | $0.63 | 3.36 |
| 2011-06-30 | 3.00 | $0.57 | 5.28 |
| 2011-03-31 | 2.91 | $0.58 | 5.02 |
| 2010-12-31 | 2.46 | $0.59 | 4.19 |
| 2010-09-30 | 3.84 | $0.58 | 6.57 |
| 2010-06-30 | 3.16 | $0.59 | 5.31 |
| 2010-03-31 | 2.79 | $0.57 | 4.88 |
| 2009-12-31 | 1.99 | $0.53 | 3.75 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.260B | $0.180B |
| Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.564B | 27.96 |
| Boston Scientific (BSX) | United States | $154.721B | 38.73 |
| Stryker (SYK) | United States | $149.011B | 31.16 |
| EssilorLuxottica (ESLOY) | France | $125.383B | 0.00 |
| Medtronic (MDT) | Ireland | $110.530B | 15.67 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.919B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.856B | 26.72 |
| ResMed (RMD) | United States | $37.567B | 28.22 |
| GE HealthCare Technologies (GEHC) | United States | $34.277B | 16.27 |
| Agilent Technologies (A) | United States | $33.923B | 22.11 |
| Terumo (TRUMY) | Japan | $27.568B | 35.81 |
| Koninklijke Philips (PHG) | Netherlands | $23.187B | 16.27 |
| Insulet (PODD) | United States | $21.804B | 85.59 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.151B | 11.66 |
| Baxter (BAX) | United States | $15.652B | 11.69 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.231B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.625B | 23.06 |
| Lantheus Holdings (LNTH) | United States | $5.586B | 14.09 |
| Prestige Consumer Healthcare (PBH) | United States | $4.010B | 17.91 |
| Perrigo (PRGO) | Ireland | $3.653B | 9.26 |
| Haemonetics (HAE) | United States | $3.592B | 16.36 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.330B | 27.68 |
| ICU Medical (ICUI) | United States | $3.216B | 23.72 |
| GN Store Nord (GNNDY) | Denmark | $2.307B | 19.11 |
| QuidelOrtho (QDEL) | United States | $1.941B | 13.35 |
| LeMaitre Vascular (LMAT) | United States | $1.862B | 41.62 |
| AtriCure (ATRC) | United States | $1.628B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.271B | 12.90 |
| Acuren (TIC) | United States | $1.252B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.120B | 25.19 |
| Neogen (NEOG) | United States | $1.040B | 13.31 |
| BioLife Solutions (BLFS) | United States | $1.020B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.018B | 13.02 |
| Kestra Medical Technologies (KMTS) | United States | $0.919B | 0.00 |
| InMode (INMD) | Israel | $0.889B | 8.96 |
| CeriBell (CBLL) | United States | $0.697B | 0.00 |
| Owens & Minor (OMI) | United States | $0.644B | 5.34 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.606B | 0.00 |
| Evolus (EOLS) | United States | $0.600B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.551B | 0.00 |
| Valneva SE (VALN) | France | $0.489B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.465B | 0.00 |
| Surmodics (SRDX) | United States | $0.416B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.415B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.352B | 12.94 |
| SNDL (SNDL) | Canada | $0.328B | 0.00 |
| Quanterix (QTRX) | United States | $0.328B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.283B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.273B | 23.03 |
| Sanara MedTech (SMTI) | United States | $0.252B | 0.00 |
| ZimVie (ZIMV) | United States | $0.251B | 11.39 |
| Cresco Labs (CRLBF) | United States | $0.250B | 0.00 |
| Brainsway (BWAY) | Israel | $0.248B | 65.50 |
| Aurora Cannabis (ACB) | Canada | $0.239B | 71.00 |
| Biote (BTMD) | United States | $0.234B | 6.58 |
| Canopy Growth (CGC) | Canada | $0.228B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.226B | 0.00 |
| Omeros (OMER) | United States | $0.195B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.192B | 0.00 |
| Organigram Global (OGI) | Canada | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 14.93 |
| Verano Holdings (VRNOF) | United States | $0.175B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.136B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 14.79 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Veru (VERU) | United States | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.089B | 11.54 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.083B | 0.00 |
| MacroGenics (MGNX) | United States | $0.080B | 0.00 |
| Zynex (ZYXI) | United States | $0.079B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.079B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.074B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.059B | 0.00 |
| Nephros (NEPH) | United States | $0.045B | 60.57 |
| United-Guardian (UG) | United States | $0.038B | 13.18 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |